Activities of fourth generation cephalosporins alone and in combination with gentamicin, amikacin, ciprofloxacin and levofloxacin against bloodstream Pseudomonas aeruginosa isolate

Indian Journal of Medical Microbiology

Volumn 28, Issue 1, 2010, Pages 84-85

  Ozbek, B ^a   Otuk, G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTEREMIA; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BLOODSTREAM INFECTION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

EID: 75349098947     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.58746     Document Type: Letter

References (5)

1. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474
2. Leibovici L, Konisberger H, Pitlik SD, Samra Z, Drucker M. Patients at risk for inappropriate antimicrobial therapy of bacteremia. J Intern Med 1992;231:371-374
3. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard. 7th ed. CLSI document M7-A7 Vol. 26. No 2. Wayne PA: 2006.
4. National Committee for Clinical Laboratory Standards. Methods for determining a bactericidal activity of antimicrobial agents. 7th ed. NCCLS, Wayne, PA: 1999.
5. Fish DN, Choi MK, Jung R. Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 2002;50:1045-1049